Societal CDMO Reports Second Quarter 2023 Financial Results
14 août 2023 16h05 HE
|
Societal CDMO, Inc.
Recorded Q2 Revenue of $21.8 Million Signed Multiple New Business Agreements with New and Existing Customers Secured Schedule 1 Controlled Substance Manufacturing License from Drug Enforcement...
Societal CDMO to Report Financial Results for Second Quarter 2023 on August 9, 2023
02 août 2023 16h05 HE
|
Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL), a contract development and manufacturing organization (CDMO)...
Societal CDMO Announces Expansion of Controlled Substance Manufacturing Capabilities to Address Expanding Psychedelic Drug Development Market
26 juil. 2023 07h00 HE
|
Societal CDMO, Inc.
Company Secures Schedule 1 Controlled Substance Manufacturing License from Drug Enforcement Agency, Expands on 25 Years of Manufacturing of Schedule 2 Products No Additional Investment Required to...
Biosimilar Contract Manufacturing Market Size to Hit USD 26.1 Billion by 2032 at 18.90% CAGR – Report by Market Research Future (MRFR)
24 juil. 2023 07h34 HE
|
Market Research Future
New York, USA, July 24, 2023 (GLOBE NEWSWIRE) -- Biosimilar Contract Manufacturing Market Overview: According to a Comprehensive Research Report by Market Research Future (MRFR), “Biosimilar...
Societal CDMO Selected by Spinnaker Biosciences to Provide CDMO Services to Support Clinical Development of Novel Therapeutic Candidate
10 juil. 2023 07h00 HE
|
Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., July 10, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; Nasdaq: SCTL), a contract development and manufacturing organization (CDMO) dedicated to...
Societal CDMO Reports Inducement Grants for New Staff
07 juil. 2023 16h05 HE
|
Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., July 07, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving...
Societal CDMO Signs Master Service Agreement With CivicaScript to Provide CDMO Services
29 juin 2023 07h00 HE
|
Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., June 29, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving...
Global Sterile Injectable Drugs Contract Manufacturing Outsourcing (CMO) Industry Report 2022-2032: Growing Investments & Prefilled Syringes to Offer Lucrative Growth Prospects
28 juin 2023 04h23 HE
|
Research and Markets
Dublin, June 28, 2023 (GLOBE NEWSWIRE) -- The "Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2022-2032" report has been added to ResearchAndMarkets.com's...
Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2023
21 juin 2023 16h07 HE
|
Avid Bioservices, Inc
-- Fourth Quarter and Full Year Revenue of $39.8 Million and $149.3 Million, Respectively, Both Represent a Record-High Achievement -- -- Signed $55 Million in Net New Business Orders Resulting in a...
Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2023 After Market Close on June 21, 2023
14 juin 2023 16h05 HE
|
Avid Bioservices, Inc
TUSTIN, Calif., June 14, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...